Drug Concentrations And Ratio Strengths - NAPLEX

  1. A 70-year-old man (weight 80 kg) is started on heparin for treatment of pulmonary embolism (high-alert medication). Allergies: none. Current medications: none. Labs: SCr 1.0 mg/dL, AST/ALT 26/24 units/L, platelets 210,000/mm3^3, Na 138 mEq/L. The nurse requests a heparin infusion bag prepared as 25,000 units in 500 mL of 0.9% sodium chloride. What is the final concentration of the IV preparation?
    Answer: 50 units/mL50\,\text{units/mL} The pharmaceutical calculation concept being tested is calculating the concentration of an anticoagulant IV infusion. The key mathematical principle is dividing total units by total volume to find units/mL. The correct answer 50 units/mL is best because 25,000 units / 500 mL = 50 units/mL, standard for heparin protocols. Choice A 25 units/mL is incorrect, perhaps from halving the units. Choices C 100 units/mL and D 500 units/mL are wrong, from volume errors like using 250 mL or 50 mL. A transferable clinical pearl is to monitor aPTT regularly during heparin therapy. Emphasizing high-alert medication calculations reduces thrombosis risks.
  2. A 58-year-old male (weight 78 kg) with status epilepticus requires IV fosphenytoin (narrow therapeutic index). Allergies: none. Current medications: none. Labs: SCr 1.2 mg/dL, AST 26 U/L, ALT 24 U/L, albumin 3.8 g/dL. The order is to prepare fosphenytoin 1,000 mg phenytoin equivalents (PE) diluted to a final concentration of 10 mg PE/mL for infusion. Pharmacy has fosphenytoin 50 mg PE/mL. Determine the appropriate dilution for this medication (total final volume in mL).
    Answer: 100 mL total final volume This question tests the calculation of dilution volume for a narrow therapeutic index drug (fosphenytoin), where precise concentration is essential for safe administration. The key principle is using the dilution formula: Final volume = Amount of drug / Desired concentration. The correct answer is A (100 mL total final volume) because 1,000 mg PE ÷ 10 mg PE/mL = 100 mL total volume needed. Answer B (50 mL) would create a concentration of 20 mg PE/mL, too concentrated for safe infusion. Answer C (10 mL) would yield 100 mg PE/mL, dangerously concentrated. Answer D (200 mL) would produce 5 mg PE/mL, unnecessarily dilute and increasing infusion time. When preparing narrow therapeutic index drugs like fosphenytoin, maintaining the correct concentration prevents infusion-related adverse effects such as hypotension and cardiac arrhythmias. Always calculate the volume of concentrated drug needed (20 mL in this case) and subtract from total volume to determine diluent volume (80 mL).
  3. A 4-year-old girl (weight 16 kg) is diagnosed with streptococcal pharyngitis. Allergies: none. Current medications: none. Labs: SCr 0.3 mg/dL, AST/ALT 19/17 units/L, Na 140 mEq/L, K 4.0 mEq/L. The prescriber orders azithromycin suspension and the pharmacy has a bottle labeled 200 mg/5 mL200\,\text{mg}/5\,\text{mL}. What is the concentration of the prepared solution in mg/mL\text{mg/mL}?
    Answer: 40 mg/mL40\,\text{mg/mL} The pharmaceutical calculation concept being tested is converting a labeled suspension concentration to mg/mL units. The key mathematical principle is dividing the drug amount by the corresponding volume from the label. The correct answer 40 mg/mL is best because 200 mg divided by 5 mL equals 40 mg/mL, providing the per-milliliter strength. Choice A 20 mg/mL is incorrect, possibly from dividing by 10 mL. Choices C 50 mg/mL and D 200 mg/mL are suboptimal, likely from misinterpreting the label or ignoring the volume. A transferable clinical pearl is to shake suspensions well before measuring to ensure uniform concentration. Emphasizing unit conversions aids accurate pediatric antibiotic dosing.
  4. A 9-year-old girl (weight 28 kg) is prescribed diphenhydramine for urticaria. Allergies: none. Current medications: none. Labs: SCr 0.5 mg/dL, AST/ALT 17/15 units/L, Na 139 mEq/L, K 4.2 mEq/L. The pharmacy stocks diphenhydramine liquid labeled 12.5 mg/5 mL12.5\,\text{mg}/5\,\text{mL}. What is the concentration of the prepared solution in mg/mL\text{mg/mL}?
    Answer: 2.5 mg/mL2.5\,\text{mg/mL} This question tests the concept of drug concentration conversion from a labeled ratio to milligrams per milliliter (mg/mL). The key mathematical principle involves dividing the amount of drug by the volume to express the concentration in standardized units, independent of patient-specific factors like weight or labs, which are provided as distractors. The correct answer, 2.5 mg/mL, is the best calculation because dividing 12.5 mg by 5 mL yields exactly 2.5 mg/mL, accurately reflecting the stock solution's concentration without any preparation or dilution implied. Choice A (0.25 mg/mL) is incorrect due to a common error of dividing by 50 instead of 5, perhaps misreading the label; choice B (1.25 mg/mL) might result from halving the correct value or confusing with a different formulation; choice D (12.5 mg/mL) erroneously assumes the label indicates per mL rather than per 5 mL. Always verify units when converting concentrations to avoid dosing errors in pediatric patients. A useful strategy is to double-check calculations by multiplying back: 2.5 mg/mL times 5 mL equals 12.5 mg, confirming accuracy.
  5. A 59-year-old woman (weight 70 kg) is admitted for atrial fibrillation with rapid ventricular response. Allergies: none. Current medications: metoprolol succinate 50 mg daily, apixaban 5 mg twice daily. Labs: SCr 0.9 mg/dL, AST/ALT 28/30 units/L, Mg 1.9 mg/dL, K 4.3 mEq/L. An order is written for diltiazem infusion: prepare a bag containing 125 mg diltiazem in a final volume of 250 mL of 0.9% sodium chloride. What is the final concentration of the IV preparation?
    Answer: 0.5 mg/mL0.5\,\text{mg/mL} The pharmaceutical calculation concept being tested is calculating the final concentration of an IV admixture. The key mathematical principle is dividing the total drug amount by the total volume to obtain mg/mL. The correct answer 0.5 mg/mL is best because 125 mg diltiazem in 250 mL yields 125 / 250 = 0.5 mg/mL, suitable for infusion. Choice A 0.25 mg/mL is incorrect, perhaps from doubling the volume in error. Choices C 1 mg/mL and D 2 mg/mL are suboptimal, likely from halving the volume or miscalculating the numerator. A transferable clinical pearl is to label IV bags with exact concentrations to guide infusion rate adjustments. Emphasizing accuracy in unit consistency prevents dosing errors in critical care settings.
  6. A 40-year-old woman (weight 72 kg) presents with allergic rhinitis and requests a compounded nasal solution. Allergies: none. Current medications: cetirizine 10 mg daily. Labs: SCr 0.8 mg/dL, AST/ALT 16/14 units/L, Na 140 mEq/L, K 4.2 mEq/L. The prescription is for phenylephrine nasal solution 0.25% w/v. Calculate the ratio strength for this compounded medication.
    Answer: 1:400 The pharmaceutical calculation concept being tested is converting low-percentage strength to ratio strength for nasal solutions. The key mathematical principle is ratio = 1 : (100 / percent) for w/v concentrations. The correct answer 1:400 is best because for 0.25% w/v, 100 / 0.25 = 400, indicating 1 part phenylephrine in 400 parts solution. Choice A 1:4 is incorrect, equating to 25% which is overly concentrated. Choices B 1:40 and D 1:4,000 are suboptimal, representing 2.5% and 0.025%, from decimal point errors. A transferable clinical pearl is to consider osmolarity in nasal compounds to avoid irritation. Emphasizing precise conversions ensures effective decongestant therapy.
  7. A 72-year-old man (weight 76 kg) is treated for status epilepticus. Allergies: none. Current medications: levetiracetam 1,000 mg twice daily, aspirin 81 mg daily. Labs: SCr 1.3 mg/dL, AST/ALT 24/20 units/L, Na 137 mEq/L, K 4.5 mEq/L. The provider orders phenytoin IV loading dose and requests a final concentration of 10 mg/mL10\,\text{mg/mL} in a syringe; you have phenytoin injection 50 mg/mL50\,\text{mg/mL}. Determine the appropriate dilution: how many mL of diluent must be added to 10 mL of phenytoin injection to achieve 10 mg/mL10\,\text{mg/mL}?
    Answer: Add 40 mL diluent The pharmaceutical calculation concept being tested is diluting a concentrated injection to a desired concentration while calculating added diluent volume. The key mathematical principle is determining total volume from dose and target concentration, then subtracting the stock volume to find diluent needed. The correct answer add 40 mL diluent is best because 10 mL of 50 mg/mL provides 500 mg, and 500 mg / 10 mg/mL = 50 mL total, so 50 - 10 = 40 mL diluent. Choices A, B, and C (10, 20, 30 mL) are incorrect, resulting in higher concentrations like 50, 25, or 16.7 mg/mL, risking precipitation or irritation. These distractors often stem from forgetting to subtract the stock volume or miscalculating the initial amount. A transferable clinical pearl is to consider drug solubility limits when diluting anticonvulsants like phenytoin. Emphasizing step-by-step verification of volumes ensures safe IV administration.
  8. A 4-year-old female (weight 16 kg) is diagnosed with a urinary tract infection. Allergies: none. Current medications: none. Labs: SCr 0.3 mg/dL, AST 21 U/L, ALT 15 U/L, Na 140 mEq/L. The prescription is trimethoprim-sulfamethoxazole suspension to provide trimethoprim 64 mg per dose twice daily; pharmacy has suspension 40 mg trimethoprim per 5 mL. Calculate the amount of drug required for this concentration: how many mL per dose should be dispensed?
    Answer: 8 mL per dose This question tests the calculation of medication volume for pediatric dosing, where accuracy is crucial for therapeutic efficacy and safety. The mathematical principle involves using proportion to determine volume: if 40 mg is in 5 mL, then 64 mg requires proportionally more volume. The correct answer is C (8 mL per dose) because using the proportion 40 mg/5 mL = 64 mg/X mL, solving for X gives 8 mL per dose. Answer A (6 mL) would only provide 48 mg of trimethoprim, subtherapeutic for the infection. Answer B (10 mL) would deliver 80 mg, exceeding the prescribed dose. Answer D (4 mL) would only provide 32 mg, half the required dose. When calculating pediatric doses, always double-check by multiplying the concentration by the calculated volume: 40 mg/5 mL × 8 mL = 64 mg. Educate caregivers to use appropriate measuring devices (oral syringes, not household spoons) to ensure accurate administration of liquid medications.
  9. A 58-year-old man (weight 79 kg) is admitted with alcohol withdrawal and needs thiamine IV. Allergies: none. Current medications: none. Labs: SCr 0.8 mg/dL, AST/ALT 55/48 units/L, Na 135 mEq/L, K 3.9 mEq/L. The order is thiamine 100 mg IV added to 50 mL of 0.9% sodium chloride. What is the final concentration of the IV preparation?
    Answer: 2 mg/mL2\,\text{mg/mL} The pharmaceutical calculation concept being tested is determining the final concentration of a vitamin IV admixture. The key mathematical principle is dividing the drug amount by the total volume. The correct answer 2 mg/mL is best because 100 mg / 50 mL = 2 mg/mL, appropriate for withdrawal management. Choice A 0.2 mg/mL is incorrect, perhaps from using 500 mL volume. Choices B 1 mg/mL and D 20 mg/mL are suboptimal, from doubling volume or not dividing. A transferable clinical pearl is to administer thiamine before glucose in alcoholics. Emphasizing mg/mL units ensures proper IV preparation.
  10. A 66-year-old woman (weight 62 kg) is admitted for acute decompensated heart failure and needs IV furosemide. Allergies: sulfonamides (rash). Current medications: carvedilol 12.5 mg twice daily, spironolactone 25 mg daily. Labs: SCr 1.2 mg/dL, AST/ALT 32/29 units/L, Na 132 mEq/L, K 5.1 mEq/L. The order requests furosemide 40 mg IV in a syringe diluted to a final concentration of 2 mg/mL2\,\text{mg/mL}; furosemide injection is 10 mg/mL10\,\text{mg/mL}. Determine the appropriate dilution for this medication: what final volume (mL) should the syringe contain?
    Answer: 20 mL The pharmaceutical calculation concept being tested is calculating the final volume for a diluted IV diuretic to achieve a target concentration. The key mathematical principle is dividing the dose by the desired concentration to find total volume. The correct answer 20 mL is best because 40 mg / 2 mg/mL = 20 mL, ensuring safe push administration. Choice A 10 mL is incorrect, yielding 4 mg/mL which is too concentrated. Choices C 40 mL and D 50 mL are wrong, resulting in 1 mg/mL or 0.8 mg/mL, unnecessarily dilute. A transferable clinical pearl is to monitor electrolytes post-diuretic administration. Emphasizing stock concentration in dilutions avoids vein irritation.
  11. A 47-year-old man (weight 92 kg) is treated for hypoglycemia and needs a dextrose infusion. Allergies: none. Current medications: insulin glargine 20 units nightly. Labs: SCr 0.9 mg/dL, AST/ALT 22/20 units/L, glucose 48 mg/dL, Na 137 mEq/L, K 4.6 mEq/L. The provider orders dextrose 10% (w/v) infusion. Calculate the ratio strength for this solution.
    Answer: 1:10 The pharmaceutical calculation concept being tested is expressing IV solution percentage as ratio strength. The key mathematical principle is converting percent w/v to 1 : (100 / percent) for dextrose infusions. The correct answer 1:10 is best because for 10% w/v, 100 / 10 = 10, meaning 1 part dextrose in 10 parts solution. Choice A 1:1 is incorrect, representing 100% which is impossible. Choices B 1:5 and D 1:100 are wrong, corresponding to 20% and 1%, from misdivision. A transferable clinical pearl is to infuse dextrose slowly in hypoglycemia to avoid rebound. Emphasizing w/v for IVs ensures osmotic balance.
  12. A 6-year-old boy (weight 20 kg) is seen for acute otitis media. Allergies: none. Current medications: none. Labs: SCr 0.4 mg/dL, AST/ALT 20/18 units/L, Na 139 mEq/L, K 4.1 mEq/L. The prescriber orders amoxicillin 45 mg/kg/day45\,\text{mg/kg/day} by mouth divided every 12 hours for 10 days; the pharmacy stocks amoxicillin suspension 400 mg/5 mL400\,\text{mg}/5\,\text{mL}. What is the concentration of the prepared solution in mg/mL\text{mg/mL}?
    Answer: 80 mg/mL80\,\text{mg/mL} The pharmaceutical calculation concept being tested is converting a labeled concentration to a different unit for oral suspensions. The key mathematical principle is dividing the amount of drug by the volume to find mg/mL, independent of patient-specific dosing. The correct answer 80 mg/mL is best because 400 mg divided by 5 mL equals 80 mg/mL, accurately reflecting the stock concentration. Choice A 40 mg/mL is incorrect, halving the actual strength perhaps by misreading the label. Choices C 100 mg/mL and D 400 mg/mL are wrong, possibly from ignoring the volume or confusing with daily dose calculations. A transferable clinical pearl is to verify suspension concentrations before calculating pediatric doses to avoid under- or overdosing. Emphasizing unit conversions like mg per mL ensures safe dispensing and administration in children.
  13. A 61-year-old woman (weight 58 kg) is admitted for severe nausea and vomiting. Allergies: ondansetron (headache). Current medications: sertraline 50 mg daily. Labs: SCr 0.7 mg/dL, AST/ALT 20/19 units/L, Na 136 mEq/L, K 3.8 mEq/L. The provider orders metoclopramide 10 mg IV to be prepared in a syringe at a concentration of 2 mg/mL2\,\text{mg/mL}; metoclopramide injection is available as 5 mg/mL5\,\text{mg/mL}. Calculate the amount of drug required for this concentration (mL of metoclopramide injection needed) to prepare 5 mL final volume.
    Answer: 2 mL The pharmaceutical calculation concept being tested is calculating the volume of stock solution needed for a diluted IV preparation at a specific concentration and final volume. The key mathematical principle is determining drug amount from final concentration and volume, then dividing by stock concentration. The correct answer 2 mL is best because 10 mg total (from 2 mg/mL × 5 mL) divided by 5 mg/mL stock equals 2 mL needed. Choice A 1 mL is incorrect, halving the required volume and yielding only 5 mg total. Choices C 4 mL and D 5 mL are wrong, providing excess drug like 20 mg or 25 mg, possibly from confusing final and stock concentrations. A transferable clinical pearl is to prepare small-volume IV pushes with precise dilutions to minimize waste. Emphasizing calculation of total dose first ensures safe antiemetic administration.
  14. A 56-year-old female (weight 68 kg) is receiving total parenteral nutrition (TPN) and needs potassium supplementation. Allergies: none. Current medications: furosemide 20 mg IV daily, pantoprazole 40 mg IV daily. Labs: SCr 0.9 mg/dL, AST 20 U/L, ALT 19 U/L, K 3.2 mEq/L. The TPN bag volume is 2,000 mL, and the order is to add potassium chloride 60 mEq total; pharmacy has potassium chloride injection 2 mEq/mL. What is the final concentration of potassium chloride in the TPN solution in mEq/L?
    Answer: 30 mEq/L This question tests the calculation of electrolyte concentration in large-volume parenteral solutions, crucial for safe TPN administration. The key principle is converting total mEq to concentration in mEq/L by accounting for volume in liters: 2,000 mL = 2 L. The correct answer is B (30 mEq/L) because 60 mEq total ÷ 2 L = 30 mEq/L of potassium chloride in the final TPN solution. Answer A (20 mEq/L) underestimates the concentration by using 3 L instead of 2 L. Answer C (60 mEq/L) incorrectly uses 1 L instead of 2 L for the calculation. Answer D (15 mEq/L) represents a calculation error of halving the correct concentration. When preparing TPN with electrolyte additives, always verify final concentrations to ensure they fall within safe ranges for peripheral or central administration. Remember that potassium concentration limits help prevent cardiac arrhythmias, and calculations should account for all electrolyte sources in the TPN formula.
  15. A 57-year-old man (weight 88 kg) is admitted for acute agitation requiring haloperidol IM. Allergies: none. Current medications: none. Labs: SCr 1.0 mg/dL, AST/ALT 23/20 units/L, Na 139 mEq/L, K 4.1 mEq/L. The order is to prepare haloperidol 5 mg in a syringe with a final volume of 2 mL; haloperidol injection is available as 5 mg/mL5\,\text{mg/mL}. What is the concentration of the prepared solution?
    Answer: 2.5 mg/mL2.5\,\text{mg/mL} The pharmaceutical calculation concept being tested is determining the concentration of a diluted IM injection given dose and final volume. The key mathematical principle is dividing the total dose by the final volume to find mg/mL. The correct answer 2.5 mg/mL is best because 5 mg in 2 mL yields 5 / 2 = 2.5 mg/mL, appropriate for administration. Choice A 1.25 mg/mL is incorrect, perhaps from assuming a 4 mL volume. Choices C 5 mg/mL and D 10 mg/mL are wrong, matching undiluted stock or double strength. A transferable clinical pearl is to dilute antipsychotics for IM use to reduce injection site pain. Emphasizing final volume calculations promotes safe psychiatric care.
  16. A 61-year-old female (weight 65 kg) is admitted with new-onset atrial fibrillation and is started on a heparin infusion (high-alert medication). Allergies: none. Current medications: metoprolol tartrate 25 mg PO twice daily, levothyroxine 100 mcg PO daily. Labs: SCr 0.9 mg/dL, AST 23 U/L, ALT 20 U/L, platelets 210,000/mm3^3. Pharmacy is to prepare heparin 25,000 units in 250 mL of 0.9% sodium chloride. What is the concentration of the prepared solution in units/mL?
    Answer: 100 units/mL This question tests the calculation of drug concentration for a high-alert medication (heparin), where precision is critical for patient safety. The mathematical principle is straightforward division: total units divided by total volume equals concentration in units/mL. The correct answer is C (100 units/mL) because 25,000 units ÷ 250 mL = 100 units/mL, a standard concentration for heparin infusions. Answer A (50 units/mL) represents a calculation error of halving the actual concentration. Answer B (250 units/mL) incorrectly divides volume by units instead of units by volume. Answer D (10 units/mL) is a decimal place error, being 10 times too dilute. When preparing heparin infusions, always use standardized concentrations when possible to reduce medication errors, and verify calculations independently as heparin dosing errors can cause life-threatening bleeding or thrombosis. Document all calculations and have a second pharmacist verify high-alert medication preparations before dispensing.
  17. A 1:4000 w/v solution contains how many milligrams per 25 mL?
    Answer: 6.25 mg A 1:4000 w/v solution contains 1 gram, or 1000 mg, in 4000 mL. Since 4000 mL divided by 25 mL is 160, you divide 1000 mg by 160 and get 6.25 mg. The tempting error is 0.625 mg, which would be 1:40,000 instead of 1:4000.
  18. A 25-year-old woman (weight 55 kg) requests a compounded topical preparation for hyperpigmentation. Allergies: none. Current medications: none. Labs: SCr 0.7 mg/dL, AST/ALT 15/14 units/L, Na 140 mEq/L, K 4.1 mEq/L. The prescription is for hydroquinone cream 4% w/w. Calculate the ratio strength of this ingredient in the final product.
    Answer: 1:25 The pharmaceutical calculation concept being tested is converting higher percentage strength to ratio in topical compounds. The key mathematical principle is ratio as 1 : (100 / percent) for w/w creams. The correct answer 1:25 is best because for 4% w/w, 100 / 4 = 25, indicating 1 part hydroquinone in 25 parts cream. Choice A 1:4 is incorrect, representing 25% which is hazardous. Choices C 1:40 and D 1:400 are wrong, matching 2.5% and 0.25%, from calculation slips. A transferable clinical pearl is to advise sun protection with depigmenting agents. Emphasizing accurate ratios prevents skin irritation.
  19. A 38-year-old woman (weight 68 kg) has a fungal rash and needs a compounded topical preparation. Allergies: none. Current medications: none. Labs: SCr 0.8 mg/dL, AST/ALT 20/18 units/L, Na 140 mEq/L, K 4.0 mEq/L. The prescription is for a cream containing clotrimazole 1% w/w. Calculate the ratio strength for this compounded medication.
    Answer: 1:100 The pharmaceutical calculation concept being tested is converting percentage to ratio strength for antifungal creams. The key mathematical principle is ratio strength as 1 : (100 / percent) for w/w formulations. The correct answer 1:100 is best because for 1% w/w, 100 / 1 = 100, indicating 1 part clotrimazole in 100 parts cream. Choice A 1:10 is incorrect, matching 10% which is too potent. Choices C 1:1,000 and D 10:1 are suboptimal, representing 0.1% or reverse ratio errors. A transferable clinical pearl is to counsel on application duration for topicals. Emphasizing w/w basis ensures compounding accuracy.
  20. A 63-year-old man (weight 74 kg) is in the ICU with septic shock requiring norepinephrine. Allergies: none. Current medications: none. Labs: SCr 1.6 mg/dL, AST/ALT 45/40 units/L, Na 134 mEq/L, K 4.8 mEq/L. The order is to prepare norepinephrine 8 mg in 250 mL of 5% dextrose in water. What is the final concentration of the IV preparation?
    Answer: 32 mcg/mL32\,\text{mcg/mL} The pharmaceutical calculation concept being tested is calculating the concentration of a vasopressor IV infusion, including unit conversion to mcg/mL. The key mathematical principle is dividing total drug by volume, then converting mg to mcg for clinical relevance. The correct answer 32 mcg/mL is best because 8 mg / 250 mL = 0.032 mg/mL, and 0.032 × 1000 = 32 mcg/mL. Choice A 8 mcg/mL is incorrect, quartering the value perhaps by misdividing. Choices B 16 mcg/mL and D 64 mcg/mL are wrong, from halving or doubling errors in conversion. A transferable clinical pearl is to standardize vasopressor concentrations in ICUs for rapid titration. Emphasizing mcg/mL units prevents overdose in shock management.

Start this quiz